Article

R&D Costs and Returns to New Drug Development: A Review of the Evidence

Joseph A. DiMasi and Henry G. Grabowski

in The Oxford Handbook of the Economics of the Biopharmaceutical Industry

Published in print April 2012 | ISBN: 9780199742998
Published online September 2012 | | DOI: http://dx.doi.org/10.1093/oxfordhb/9780199742998.013.0002

Series: Oxford Handbooks

 R&D Costs and Returns to New Drug Development: A Review of the Evidence

More Like This

Show all results sharing these subjects:

  • Economics
  • Health, Education, and Welfare
  • Financial Institutions and Services

GO

Show Summary Details

Preview

This article reviews the extensive literature on R&D costs and returns. The first section focuses on R&D costs and the various factors that have affected the trends in real R&D costs over time. The second section considers economic studies on the distribution of returns in pharmaceuticals for different cohorts of new drug introductions. It also reviews the use of these studies to analyze the impact of policy actions on R&D costs and returns. The final section concludes and discusses open questions for further research.

Keywords: research and development costs; economic studies; pharmaceuticals; new drugs; returns; pharmaceutical industry; drug development costs

Article.  9648 words. 

Subjects: Economics ; Health, Education, and Welfare ; Financial Institutions and Services

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.